Wednesday, January 19, 2022

Adar Poonawalla

SII vaccine for 3+ kids by mid-2022: Adar Poonawalla

Mumbai: The Pune-based Serum Institute of India (SII) will launch Covavax -- its vaccine for children aged above 3 years -- in the next...

SII begins manufacturing Covovax; to start trial in kids in July

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune," he shared in a tweet on Friday.

Adar Poonawalla exits Panacea Biotec

As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.

Covishield production in full swing in Pune, says Poonawalla

India rolled out the third phase of its COVID-19 vaccination drive for those in the age group of 18-45 years on Saturday.

AP places order for over 4 cr doses each of Covaxin, Covishield

Amaravati: The Andhra Pradesh government on Saturday placed an order for purchase of 4.08 crore doses each of Covaxin and Covishield for vaccinating 2.04...

Hope to launch Covovax by September this year, says Adar Poonawalla

Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.

Svasti Microfinance raises Rs 31 cr

The MFI services around 1,87,500 customers across 63 branches spread over 4 states, aggregating a loan portfolio of around Rs 400 crore.

Will send Covishield to Canada in less than a month: Adar Poonawalla

Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine.

Serum Institute applies for trials of another COVID-19 vaccine

The city-based firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca.

Bharat Biotech, SII pledge for smooth rollout of COVID vaccines

The Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 vaccine Covishield

Poonawalla of Serum Institute among 6 named ‘Asians of the Year’ by Singapore daily

Poonawalla joined the Serum Institute of India in 2001 and became the CEO of Serum Institute with complete control of the day-to-day operations of the company in 2011.

Serum Institute of India CEO expresses delight at Covishield vaccine efficacy

The Oxford-AstraZeneca vaccine is being made in partnership with Serum Institute.

Latest News

- Advertisement -